782 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
as assessed by Blinded Independent Central Review at final analysis for these endpoints. The study remains ongoing to assess the additional key secondary
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
Annual election of Directors Majority voting standard for election of Directors Robust Lead Independent Director role Limit on public company board … ), Audit Theodore R. Samuels Lead Independent Director Retired President of Capital Guardian Trust Company Director since 2017 Ophthalmologist-in-Chief
8-K
EX-1.1
cng5 k1rfkmjn
22 Feb 24
Other Events
4:15pm
424B5
vx028d7
16 Feb 24
Prospectus supplement for primary offering
4:34pm
424B2
g4b ofv5obr9
13 Feb 24
Prospectus for primary offering
8:00am
8-K
EX-99.1
27a3t wdi3otmw
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
SC TO-T
EX-99
mgpkhuc ytj8g4il5vc3
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
k9nnwfwdvm21xkrh5
25 Jan 24
Third party tender offer statement
8:13am